Russian CJSC Innovative Research and Production Center "Peptogen" was founded in 2005 with the participation of the Institute of Molecular Genetics of the Russian Academy of Sciences. The aim of the company is to produce medication developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and to conduct its own scientific research development. JSC IRPC "Peptogen" develops and produces next generation drugs, which meet international pharmaceutical quality standards ("Good Manufacturing Practic" (GMP). Regulatory peptides-based drugs are used both to improve the brain functions of healthy people, for example, to improve memory, attention, mental performance, and to treat severe neurological diseases, such as strokes, craniocerebral trauma, ischemic attacks and their possible consequences and others, as well as to prevent the named illnesses. Since 2013 IRPC "Peptogen" is permanently located at the territory of "Technopark Strogino".